PTEN (Tumor Suppressor Oncoprotein) (PTEN/2110), 0.2mg/mL

Primary

Primary Antibodies Only

Purified, with BSA

Room Temperature (Next day)

55 kDa

PTEN (phosphatidylinositol-3, 4, 5-trisphosphate 3-phosphatase) contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. It was identified as a tumor suppressor that is mutated in a large number of cancers, including sporadic brain, breast, kidney, and prostate cancers.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.

Stable at room temperature or 37°C (98°F) for 7 days.

Primary and secondary antibodies for multiple methodologyimmunostaining detection application

0.2 mg/mL

Guaranteed for at least 24 months from date of receipt when stored as recommended

Monoclonal

PTEN

MCF-7 or HeLa Cells. Prostate, Breast, Liver, Renal Carcinoma.

Monospecific

IHC (FFPE) (verified)

BZS, DEC, GLM2, MHAM, Mutated in Multiple Advanced Cancers 1 (MMAC1), MMAC1 phosphatase and tensin homolog deleted on chromosome 10, Phosphatase and Tensin Homolog, Phosphatase and tensin like protein, Phosphatidylinositol 3, 4, 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase, PTEN, PTEN1, TEP1

#2110